Search

Author/Creator Forero, Andres

1. A phase 2 study of inotuzumab ozogamicin in patients with indolent B‐cell non‐Hodgkin lymphoma refractory to rituximab alone, rituximab and chemotherapy, or radioimmunotherapy. (22nd April 2016)

Authors:
Goy, Andre; Forero, Andres; Wagner‐Johnston, Nina; Christopher Ehmann, W.; Tsai, Michaela; Hatake, Kiyohiko; Ananthakrishnan, Revathi; Volkert, Angela; Vandendries, Erik; Ogura, Michinori
Journal:
British journal of haematology
Issue:
Volume 174:Number 4(2016)
Page Start:
571
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Concordance with NCCN treatment guidelines: Relations with health care utilization, cost, and mortality in breast cancer patients with secondary metastasis. Issue 21 (14th October 2018)

Authors:
Rocque, Gabrielle B.; Williams, Courtney P.; Kenzik, Kelly M.; Jackson, Bradford E.; Azuero, Andres; Halilova, Karina I.; Ingram, Stacey A.; Pisu, Maria; Forero, Andres; Bhatia, Smita
Journal:
Cancer
Issue:
Volume 124:Issue 21(2018)
Page Start:
4231
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Safety and disease response to MEDI-551, an anti-CD19 antibody, in chronic lymphocytic leukemia patients previously treated with rituximab. (7th November 2013)

Authors:
Forero, Andres; Hamadani, Mehdi; Kipps, Thomas; Fanale, Michelle; Cuneo, Antonio; Perez de Oteyza, Jaime; Gladstone, Douglas; Andre, Marc; Bellam, Naresh; Goswami, Trishna; Ibrahim, Ramy; Schneider, Amy; Liang, Meina; Eck, Steven; Elgeioushi, Nairouz; Herbst, Ronald; Cheson, Bruce D
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 1(2013)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Impact of Guideline‐Discordant Treatment on Cost and Health Care Utilization in Older Adults with Early‐Stage Breast Cancer. (17th August 2018)

Authors:
Williams, Courtney P.; Kenzik, Kelly M.; Azuero, Andres; Williams, Grant R.; Pisu, Maria; Halilova, Karina I.; Ingram, Stacey A.; Yagnik, Supriya K.; Forero, Andres; Bhatia, Smita; Rocque, Gabrielle B.
Journal:
Oncologist
Issue:
Volume 24:Number 1(2019)
Page Start:
31
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade. (30th April 2019)

Authors:
Prat, Aleix; Pascual, Tomás; De Angelis, Carmine; Gutierrez, Carolina; Llombart-Cussac, Antonio; Wang, Tao; Cortés, Javier; Rexer, Brent; Paré, Laia; Forero, Andres; Wolff, Antonio C; Morales, Serafín; Adamo, Barbara; Brasó-Maristany, Fara; Vidal, Maria; Veeraraghavan, Jamunarani; Krop, Ian; Galv...
Journal:
Journal of the National Cancer Institute
Issue:
Volume 112:Number 1(2020)
Page Start:
46
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer1: Translational Breast Cancer Research Consortium trial 017. Issue 10 (21st February 2013)

Authors:
De Los Santos, Jennifer F.; Cantor, Alan; Amos, Keith D.; Forero, Andres; Golshan, Mehra; Horton, Janet K.; Hudis, Clifford A.; Hylton, Nola M.; McGuire, Kandace; Meric‐Bernstam, Funda; Meszoely, Ingrid M.; Nanda, Rita; Hwang, E. Shelley
Journal:
Cancer
Issue:
Volume 119:Issue 10(2013)
Page Start:
1776
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. The antitumor effects of entinostat in ovarian cancer require adaptive immunity. Issue 24 (13th November 2018)

Authors:
Smith, Haller J.; McCaw, Tyler R.; Londono, Angelina I.; Katre, Ashwini A.; Meza‐Perez, Selene; Yang, Eddy S.; Forero, Andres; Buchsbaum, Donald J.; Randall, Troy D.; Straughn, Jr, J. Michael; Norian, Lyse A.; Arend, Rebecca C.
Journal:
Cancer
Issue:
Volume 124:Issue 24(2018)
Page Start:
4657
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer1. Issue 10 (21st February 2013)

Authors:
De Los Santos, Jennifer F.; Cantor, Alan; Amos, Keith D.; Forero, Andres; Golshan, Mehra; Horton, Janet K.; Hudis, Clifford A.; Hylton, Nola M.; McGuire, Kandace; Meric‐Bernstam, Funda; Meszoely, Ingrid M.; Nanda, Rita; Hwang, E. Shelley
Journal:
Cancer
Issue:
Volume 119:Issue 10(2013)
Page Start:
1776
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗